ArticleEcancermedicalscience2025
Trends in colorectal cancer cases at a Mexican secondary-care hospital.
Article in Ecancermedicalscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Colorectal cancer (CRC) is a major global health issue, ranking fourth in incidence and third in cancer-related deaths. In 2022, it was most prevalent in Asia, Europe and North America. Although rates in Latin America, including Mexico, are lower, they still represent a substantial public health concern. However, CRC data in Mexico are limited and outdated. Aim: This study aimed to assess the incidence trends of CRC in a secondary-level hospital in Mexico from 2011 to 2023. Methods: A retrospective analysis was conducted on 819 individuals with CRC at Regional General Hospital 251 (Mexican Social Security Institute) in Metepec, Mexico. Incidence rates were calculated per 100,000 inhabitants and stratified by sex, age group, tumour site and body mass index. Trend analysis was performed using Joinpoint regression models to estimate annual percent change (APC). Results: CRC incidence showed a significant upward trend (APC = 8.81%; Conclusion: CRC incidence increased significantly over the last decade, with a recent drop likely influenced by the COVID-19 pandemic. Despite some limitations, this is the first study of CRC trends at a secondary-level hospital in Mexico that underscores the need for enhanced screening and timely diagnosis strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.